What amount sold does PRIMECAP US MidCap Growth Strategy report in Form D filings?

The latest linked filings report $146.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was PRIMECAP US MidCap Growth Strategy's most recent SEC filing?

PRIMECAP US MidCap Growth Strategy's most recent Form D filing was on 2026-08-05.

How many investors does PRIMECAP US MidCap Growth Strategy have?

The most recent Form D filing lists 2 investor(s).

PRIMECAP US MidCap Growth Strategy

CIK: 0002108463·Pooled Investment Fund·WOBURN, MA·Other·Founded 2026

Reported Sold

$146,350,000

Total Filings

Identified Offerings

Last Filed

Aug 5, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Aug 5, 2026Form D — New notice

Reported sold: $146,350,000 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$146,350,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 5, 2026	New	Indefinite	$146,350,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026